Beyond Air, a medtech company focused on using nitric oxide (NO), today announced it has received European Union CE Mark approval for the LungFit PH system. The LungFit PH system is the first device ...
Beyond Air secures a purchasing agreement with Premier for its innovative LungFit PH system to streamline nitric oxide supply in hospitals. Beyond Air, Inc. has announced that it has been awarded a ...
GARDEN CITY, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on ...